PT
PTLKF.US PT Lippo Karawaci Tbk
- Market cap
- USD 35.4M
- P/E
- -
- P/B
- 0.40x
- ROE
- 5.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is PTLKF.US undervalued?
Graham numberThe Graham number of PT Lippo Karawaci Tbk cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PT Lippo Karawaci Tbk fundamental analysis
No fundamental analysis for PT Lippo Karawaci Tbk yet.
PT Lippo Karawaci Tbk stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PT Lippo Karawaci Tbk
PT Lippo Karawaci Tbk engages in real estate development, healthcare and lifestyle businesses in Indonesia. The company is also involved in investment, development, trading, home care, and financing activities; installation and water treatment; town management; urban development; marketing and building management; clean water and waste management; hotel management; catering service; and provision of accommodation and burial services. PT Lippo Karawaci Tbk founded in 1990 and…
Full company profilePT Lippo Karawaci Tbk financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
PT Lippo Karawaci Tbk annual financial statements (IDR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 10.3T | 10.9T | 12.3T | 12.2T | 11.8T | 16.1T | 14.7T | 16.8T | 11.3T | 8.87T | 7.02T |
| Gross Profit | 4.30T | 4.57T | 5.78T | 4.45T | 4.13T | 5.55T | 6.15T | 7.09T | 4.79T | 2.54T | 2.76T |
| Operating Income | 1.81T | 1.18T | 847B | -388B | -84.4B | 625B | -39.1B | 3.69T | 20.3T | 614B | 778B |
| EBITDA | 2.44T | 2.09T | 3.57T | 372B | -5.53T | 3.85T | 1.42T | 4.41T | 21.5T | 1.13T | 1.32T |
| Net Income | 882B | 614B | 695B | -2.06T | -9.64T | -1.62T | -2.33T | 50.1B | 18.7T | 471B | 1.64T |
| EPS | 31 | 21 | 24 | -46 | -136 | -23 | -51 | 1.10 | 410 | 6.64 | 23 |
| Balance Sheet | |||||||||||
| Total Assets | 45.6T | 56.8T | 49.8T | 55.1T | 51.9T | 52.1T | 49.9T | 49.6T | 53.8T | 49.4T | 48.4T |
| Total Liabilities | 23.5T | 26.9T | 24.3T | 20.7T | 28.3T | 29.6T | 30.7T | 30.0T | 22.8T | 18.2T | 16.4T |
| Shareholders' Equity | 18.6T | 22.8T | 18.8T | 28.8T | 19.5T | 18.8T | 15.3T | 15.3T | 29.9T | 30.2T | 31.1T |
| Cash & Short-term Investments | 9.63T | 9.70T | 4.75T | 5.03T | 3.33T | 5.13T | 2.84T | 2.79T | 5.61T | 2.24T | 1.61T |
| Total Debt | 13.7T | 13.8T | 14.9T | 12.3T | 17.9T | 19.9T | 21.2T | 20.3T | 10.2T | 9.67T | 8.91T |
| Cash Flow | |||||||||||
| Operating Cash Flow | -559B | -4.51T | -1.71T | -4.54T | -2.37T | 1.63T | -1.13T | 2.06T | 1.74T | -1.63T | -419B |
| Capital Expenditure | 530B | 1.13T | 910B | 651B | 510B | 453B | 929B | 1.11T | 544B | 196B | 157B |
| Free Cash Flow | -1.09T | -5.64T | -2.62T | -5.19T | -2.88T | 1.17T | -2.06T | 954B | 1.20T | -1.83T | -576B |
| Ratios | |||||||||||
| ROE | 4.8% | 2.7% | 3.7% | -7.2% | -49.5% | -8.7% | -15.2% | 0.3% | 62.8% | 1.6% | 5.3% |
| ROA | 1.9% | 1.1% | 1.4% | -3.7% | -18.6% | -3.1% | -4.7% | 0.1% | 34.9% | 1.0% | 3.4% |
| Net Profit Margin | 8.5% | 5.6% | 5.7% | -16.9% | -81.6% | -10.1% | -15.9% | 0.3% | 165.2% | 5.3% | 23.4% |
| Debt to Equity | 0.74x | 0.61x | 0.79x | 0.43x | 0.92x | 1.06x | 1.38x | 1.32x | 0.34x | 0.32x | 0.29x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
PT Lippo Karawaci Tbk dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 25, 2018
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | IDR 55.9M | 0.00 | 0.1% |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | USD 61.4B | 2.14 | 8.8% |
| 2017 | IDR 44.2B | 1.54 | 7.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 63:50 on Oct 14, 2019.
Who owns PT Lippo Karawaci Tbk
- Insiders 67.65%
- Institutions 6.35%
- Public & others 26.00%
- Shares outstanding 70.9B
- Free float 34.1B
PT Lippo Karawaci Tbk company profile
- Company name
- PT Lippo Karawaci Tbk
- Ticker
- PTLKF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Real Estate Management & Development
- Employees
- 1,795
- Fiscal year end
- December
- Address
- Jln Boulevard Palem Raya No. 7, Tangerang, Indonesia, 15811
- Phone
- 62 21 2566 9000
- Website
- lippokarawaci.co.id
About PT Lippo Karawaci Tbk
PT Lippo Karawaci Tbk engages in real estate development, healthcare and lifestyle businesses in Indonesia. The company is also involved in investment, development, trading, home care, and financing activities; installation and water treatment; town management; urban development; marketing and building management; clean water and waste management; hotel management; catering service; and provision of accommodation and burial services. PT Lippo Karawaci Tbk founded in 1990 and is based in Tangerang, Indonesia.
PT Lippo Karawaci Tbk management
10- Mr. Marlo BudimanPresident Director · born 1975
- Mr. Fendi SantosoCFO & Director · born 1979
- Mr. Surya Tatang CFAChief Investment Officer & Director · born 1977
- Mr. Dominique Dion LeswaraChief Human Resources & Administration Officer and Director · born 1973
- Mr. Agus ArismunandarHead of Investor relations, Corporate Secretary & Director · born 1965
- Dr. Danang Kemayan JatiHead of Corporate Communications · born 1963
- Mr. Jopy RusliChief Marketing Officer · born 1964
- Mr. Alwi Rubidium SjaafChief Development Officer · born 1961
- Mr. Ernest AltoHead of Internal Audit · born 1972
- Ms. Caroline RiadyVice President Director & CEO of PT Siloam International Hospitals Tbk · born 1984